PT975671E - Processo para purificacao ou fraccionamento cromatografico do factor de von willebrand a partir de uma materia-prima contendo o fvw - Google Patents

Processo para purificacao ou fraccionamento cromatografico do factor de von willebrand a partir de uma materia-prima contendo o fvw

Info

Publication number
PT975671E
PT975671E PT98901239T PT98901239T PT975671E PT 975671 E PT975671 E PT 975671E PT 98901239 T PT98901239 T PT 98901239T PT 98901239 T PT98901239 T PT 98901239T PT 975671 E PT975671 E PT 975671E
Authority
PT
Portugal
Prior art keywords
fvw
purification
raw material
material containing
von willebrand
Prior art date
Application number
PT98901239T
Other languages
English (en)
Inventor
Friedrich Dorner
Hans-Peter Schwarz
Jurgen Siekmann
Peter Turecek
Johann Eibl
Bernard Fischer
Artur Mitterer
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Ag filed Critical Baxter Ag
Publication of PT975671E publication Critical patent/PT975671E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/755Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT98901239T 1997-02-04 1998-01-30 Processo para purificacao ou fraccionamento cromatografico do factor de von willebrand a partir de uma materia-prima contendo o fvw PT975671E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0017697A AT404358B (de) 1997-02-04 1997-02-04 Verfahren zur chromatographischen reinigung bzw. fraktionierung von von willebrand-faktor aus einem vwf-hältigen ausgangsmaterial

Publications (1)

Publication Number Publication Date
PT975671E true PT975671E (pt) 2004-02-27

Family

ID=3483577

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98901239T PT975671E (pt) 1997-02-04 1998-01-30 Processo para purificacao ou fraccionamento cromatografico do factor de von willebrand a partir de uma materia-prima contendo o fvw

Country Status (10)

Country Link
US (1) US6414125B1 (pt)
EP (1) EP0975671B1 (pt)
JP (1) JP2001509170A (pt)
AT (1) AT404358B (pt)
CA (1) CA2279494A1 (pt)
DE (1) DE59809727D1 (pt)
DK (1) DK0975671T3 (pt)
ES (1) ES2207812T3 (pt)
PT (1) PT975671E (pt)
WO (1) WO1998033820A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1148063A1 (de) * 2000-04-18 2001-10-24 Octapharma AG Haemostatisch aktives vWF enthaltendes Präparat und Verfahren zu seiner Herstellung
US20040185042A1 (en) 2003-03-20 2004-09-23 Friedrich Scheiflinger Immunoadsorption of anti-von Willebrand Factor cleaving protease antibodies
FR2920429B1 (fr) * 2007-08-30 2012-10-05 Lfb Biotechnologies Procede de purification du facteur viii et du facteur von willebrand
WO2011017414A2 (en) 2009-08-04 2011-02-10 Baxter International Inc. Transgenic mouse lacking endogenous fviii and vwf - a model of hemophilia a
US9488625B2 (en) 2010-12-15 2016-11-08 Baxalta GmbH Purification of factor VIII using a conductivity gradient
AU2013203043B2 (en) 2013-03-15 2016-10-06 Takeda Pharmaceutical Company Limited Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2929144A1 (de) 1979-07-19 1981-02-12 Behringwerke Ag Verfahren zur herstellung von kollagen
US4540573A (en) 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
AT389815B (de) 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
AT390560B (de) 1986-05-30 1990-05-25 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern
AT391808B (de) 1986-11-03 1990-12-10 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion
FR2673632A1 (fr) 1991-03-08 1992-09-11 Lille Transfusion Sanguine Procede de preparation de concentre de facteur von willebrand humain de tres haute purete, approprie a un usage therapeutique.
AT402789B (de) 1991-03-25 1997-08-25 Immuno Ag Pharmazeutische präparation auf basis von plasmaproteinen
AT399818B (de) 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
JP3133338B2 (ja) 1992-12-16 2001-02-05 イムノ・アクチエンゲゼルシャフト ウイルス的に安全な生物学的組成物の調製方法
AT402788B (de) 1993-08-03 1997-08-25 Immuno Ag Virussichere blutgerinnungsfaktor xiii-präparation

Also Published As

Publication number Publication date
EP0975671A1 (de) 2000-02-02
DE59809727D1 (de) 2003-10-30
US6414125B1 (en) 2002-07-02
ATA17697A (de) 1998-03-15
DK0975671T3 (da) 2004-01-19
ES2207812T3 (es) 2004-06-01
CA2279494A1 (en) 1998-08-06
AT404358B (de) 1998-11-25
JP2001509170A (ja) 2001-07-10
WO1998033820A1 (de) 1998-08-06
EP0975671B1 (de) 2003-09-24

Similar Documents

Publication Publication Date Title
DE69421885D1 (de) Oberflächenmaterial für Festphase-Extraktionsreinigung von DNA
DE69517559D1 (de) Verfahren zur Herstellung von anorganisches Material enthaltenden Verbundwerkstoffen
DE69528730D1 (de) Herstellung von Schwefelenthaltenden Organosiliziumverbindungen
DE69530520D1 (de) Computerprogrammprodukt zur Verwendung von Mehrfachbefehlssätzen
BR9709622A (pt) Processo para produção de compostos aromáticos a partir de hidrocarbonetos alifáticos
DE69626392D1 (de) Stabile reagenzien zur herstellung von radiopharmazeutika
DE69019074D1 (de) Verfahren zur Fraktionierung von Plasmaproteinen.
DE69525132D1 (de) Verfahren zur Kristallisierung von Polyester-Harzen
BR9510012A (pt) Processo para a purificação de uma composição de 1,3-propanodiol contendo carbonila
BR9302418A (pt) Composicao adesiva re-polpavel e processo para a producao de uma composicao adesiva re-polpavel de multiplos componentes
EP0719854A3 (de) Verfahren zur Fraktionierung bzw. Raffination von lipiden Naturstoffen
DE69502384D1 (de) Prozess zur herstellung von polyarylenetherketonen
FI961619A (fi) Menetelmä epäpuhtaan alumiinioksidin käsittelemiseksi
DE69312205D1 (de) Reinigungsmethode von Rohprodukt
PT789767E (pt) Processo para a producao de proteinas de papilomavirus purificadas
PT975671E (pt) Processo para purificacao ou fraccionamento cromatografico do factor de von willebrand a partir de uma materia-prima contendo o fvw
DE69422467D1 (de) Fraktioniermethode für Nukleotidfragmente
DE69531424D1 (de) Verfahren zur Reinigung von Halosilanen
DE59607348D1 (de) Dreifachsäulenverfahren zur Tieftemperaturzerlegung von Luft
GB9718518D0 (en) Fractionation of Hemicellulosic Materials
DE19581758T1 (de) Befestigungsmaschine zur Befestigung von Verschlüssen
DE69422357D1 (de) Schmelzverfahren zur Synthese von Zinn(II)-terephthalat
DE69417891D1 (de) Raffinierungsverfahren von cyclodextrin
DE69407906D1 (de) Herstellen von Mineralfasermaterial
DE69612815D1 (de) Verfahren zur Heissfraktionierung von Organosilanen